CD4 Count Test (T-Cell Count)

CD4 count reference ranges

CD4 count and HIV treatment

CD4 count vs HIV viral load

What the Switching Trials Showed

Whether CD4 count is good enough to decide when treatment has failed was tested directly, and the answer is more interesting than a simple yes or no.

A randomised trial in Thailand followed 716 adults starting antiretroviral therapy, switching them to a second-line regimen either on CD4 criteria or on viral load. At three years the rate of clinical failure, death, a new AIDS-defining illness, or a CD4 below 50, was 7.4% in the CD4 group and 8.0% in the viral load group. On that measure CD4 monitoring was not inferior.²

The difference was in what happened along the way. People monitored by CD4 switched a great deal later: a median of 24.7 months against 11.7 months. And they spent far longer with virus replicating before anyone acted, a median of 15.8 months of viraemia at the point of switching, against 7.2 months.² Clinical outcomes at three years looked similar; the time spent with uncontrolled virus did not.

This is the practical reason viral load is the primary monitoring test wherever it is available, and CD4 has moved to a supporting role, assessing how much immune damage exists at diagnosis, deciding whether prophylaxis against opportunistic infections is needed, and tracking recovery. A stable CD4 is reassuring, but it is not evidence that treatment is working, because it can remain stable while it is not.

None of this makes CD4 obsolete. The trial authors framed their result as reassurance for programmes still relying on CD4 where viral load is not yet available.² Where both exist, viral load answers the question CD4 answers slowly.

Questions to ask your HIV doctor

• What is my current CD4 count and is it rising on treatment?
• Is my viral load undetectable?
• Do I need prophylaxis against opportunistic infections?
• How often should I have my CD4 and viral load checked?

CD4 count vs CD4% vs viral load: how they compare

CD4 is one of several numbers tracked in HIV care, and each answers a different question:

In modern HIV care, viral load drives treatment decisions and CD4 tracks immune recovery — the two are read together, not in competition.

Reading your report: what your doctor actually looks at

When a doctor opens a CD4 result, the number itself is only the starting point. Here is the checklist they run through — and the same checklist helps you read your own report calmly:

1. What is the trend? CD4 wobbles with time of day, acute illness, stress and even exercise. A single dip means little; the direction across several results is what matters.
2. What is the viral load doing? A suppressed viral load with a flat CD4 is a very different situation from a detectable viral load with a falling CD4. The pair is the story.
3. Was it the same lab? CD4 methods differ, so serial counts should come from the same laboratory to keep the trend honest.
4. Were you ill? Any acute infection temporarily depresses CD4. Doctors usually recheck once you have recovered rather than reacting to a count drawn during illness.
5. Are you on treatment? Modern antiretroviral therapy aims first at viral suppression; CD4 recovery follows, sometimes slowly. Discuss the pace with your doctor rather than the number alone.

A CD4 count is a monitoring tool for people in HIV care — not a test with meaning outside that context. If a result worries you, the next step is a conversation with your treating doctor, who reads it against your viral load and history.

CD4 count test price in India: typical bands across major lab chains

CD4 testing needs flow cytometry, so it costs more than routine blood counts. Typical list-price bands:

These are approximate bands, not quotes: prices change often and vary by city, and home collection can add a small fee. Where possible, choose a NABL-accredited lab, and remember the reference range printed on your own report is the one that counts.

Frequently Asked Questions

Why a single CD4 count can be misleading

CD4 counts fluctuate considerably in the same person from day to day and even within a day. Intercurrent infection, recent vaccination, corticosteroids, time of day and normal biological variation all shift the number, sometimes substantially. Treatment decisions are therefore based on trends across several measurements rather than any single value, and an unexpectedly low count in someone clinically well is usually repeated before anything changes.

The CD4 percentage is often more stable than the absolute count because it is less affected by swings in the total lymphocyte count. Where the two disagree, the percentage frequently gives the truer picture, and it is the preferred measure in young children, whose absolute counts are naturally much higher than adults'.

How monitoring has changed

The role of CD4 counting has narrowed. Because current guidance is to start antiretroviral therapy in everyone with HIV regardless of CD4 count, the count no longer decides when to begin treatment. Its remaining uses are assessing immune damage at diagnosis, deciding whether prophylaxis against opportunistic infections is needed and when it can stop, and confirming immune recovery. In someone stable on treatment with a suppressed viral load and a CD4 count comfortably above 350 cells/mm³, routine CD4 monitoring is often reduced or stopped, with viral load taking over as the main test.

Immunological non-response

A minority of people achieve full viral suppression but recover their CD4 count poorly or not at all. This is more likely in those who started treatment at a very low count, at older age, and with co-infections such as hepatitis C. It is not treatment failure in the virological sense, and the response is usually to continue effective therapy, address co-infections and modifiable factors, and maintain prophylaxis for longer rather than to change the regimen.

Pharmacist's practical notes

CD4's biggest weakness is its wobble: time of day, a passing cold, stress, even a hard workout can move it. That is why no treatment decision rides on a single count — and why rechecking after recovery from any illness is standard practice, not evasion. Bring old reports so the trend is visible.

Adherence is the quiet variable behind most disappointing CD4 trends: missed antiretroviral doses let viral load rise and CD4 follow it down. If doses are being missed — for cost, side effects or simply routine — say so openly; pharmacists can often help with reminders, side-effect management or simpler regimens. Never adjust HIV medicines yourself.

In India

Indian labs usually report CD4 as cells/µL. The test typically costs &rupee;800–&rupee;1,500, though prices vary by city and lab; government ART centres provide CD4 and viral load monitoring within the national programme.

Where possible, choose a NABL-accredited lab, and use the same laboratory for serial counts so the trend stays comparable.

References

The clinical information on this page is drawn from peer-reviewed sources indexed by the US National Library of Medicine. Links go to the source so you can read it yourself.

1. HIV and AIDS. In: StatPearls. Treasure Island (FL): StatPearls Publishing. NCBI Bookshelf NBK534860
2. Jourdain G, Le Cœur S, Ngo-Giang-Huong N, et al. Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand. PLoS Med. 2013;10(8):e1001494. PMID 23940461 · doi:10.1371/journal.pmed.1001494
3. Hoffmann CJ, Maritz J, van Zyl GU. CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone. Trop Med Int Health. 2016;21(2):219–23. PMID 26584666 · doi:10.1111/tmi.12639